Canadian Agency for Drugs and Technologies in Health. (2018). Clinical review report: Guselkumab (Tremfya) (Janssen Inc.) (Version: final.). Ottawa (ON): Canadian Agency for Drugs and Technologies in Health.
Chicago Style CitationCanadian Agency for Drugs and Technologies in Health. Clinical Review Report: Guselkumab (Tremfya) (Janssen Inc.). Version: final. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2018.
MLA CitationCanadian Agency for Drugs and Technologies in Health. Clinical Review Report: Guselkumab (Tremfya) (Janssen Inc.). Version: final. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2018.
Warning: These citations may not always be 100% accurate.